Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 172

Sort by

Sort Order Select

Journal Articles

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Blood (2022) 139 (12): 1908–1919.

https://doi.org/10.1182/blood.2021013290

Published: 2022

Includes: Supplemental data

Journal Articles

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Blood (2022) 139 (9): 1289–1301.

https://doi.org/10.1182/blood.2020008493

Published: 2022

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Blood (2017) 129 (13): 1753–1762.

https://doi.org/10.1182/blood-2016-06-724500

Published: 2017

Includes: Supplemental data

Journal Articles

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Blood (2016) 128 (24): 2819–2823.

https://doi.org/10.1182/blood-2016-05-713099

Published: 2016

Includes: Supplemental data

Journal Articles

IL-10 + regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Blood (2016) 128 (10): 1346–1361.

https://doi.org/10.1182/blood-2016-01-695122

Published: 2016

Includes: Supplemental data

Journal Articles

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Blood (2016) 128 (2): 297–312.

https://doi.org/10.1182/blood-2016-03-706317

Published: 2016

Includes: Supplemental data

Journal Articles

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Blood (2016) 127 (13): 1656–1665.

https://doi.org/10.1182/blood-2015-10-676924

Published: 2016

Includes: Supplemental data

Journal Articles

Cord Blood Derived Natural Killer Cells Engineered with a Chimeric Antigen Receptor Targeting CD19 and Expressing IL-15 Have Long Term Persistence and Exert Potent Anti-Leukemia Activity

Enli Liu, MD MS, Yijiu Tong, Gianpietro Dotti, MD, Barbara Savoldo, MD, Muharrem Muftuoglu, Kayo Kondo, PhD, Malini Mukherjee, Jordan S. Orange, MD PhD, Catherine Sobieski, Abdullah Alsuliman, Hila Shaim, MD, Nobuhiko Imahashi, MD PhD, Michael J. Keating, MD, Chitra M. Hosing, MD, Nina Shah, MD, William Wierda, MD PhD, Richard Champlin, MD, Elizabeth J. Shpall, MD, Katayoun Rezvani, MDPhD

Blood (2015) 126 (23): 3091.

https://doi.org/10.1182/blood.V126.23.3091.3091

Published: 2015

Journal Articles

Outcomes of Haploidenitical Stem Cell Transplants for De Novo Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Myeloid Leukemia Arising from MDS: The MD Anderson Experience

Reshma Ramlal, MD, Sameh Gaballa, MD, Julianne Chen, Gabriela Rondon, MD, Betul Oran, MD, Sairah Ahmed, MD, Qaiser Bashir, MD, Katayoun Rezvani, MD, PhD, David Marin, MD, Amin M. Alousi, MD, Partow Kebriaei, MD, Muzaffar Qazilbash, MD, Chitra Hosing, MD, Uday R. Popat, MD, Elizabeth J Shpall, MD, Richard Champlin, MD, Stefan O. Ciurea, MD

Blood (2015) 126 (23): 3225.

https://doi.org/10.1182/blood.V126.23.3225.3225

Published: 2015

Journal Articles

CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Basem M. William, MD, Marcos de Lima, MD, Betul Oran, MD, Richard Champlin, MD, Esperanza B Papadopoulos, MD, Sergio Giralt, MD, Bart L. Scott, MD, Joel Hetzer, PhD, Xiwei Wang, PhD, Eric Laille, MS, Barry S. Skikne, MD, Charles Craddock, MDPhD

Blood (2014) 124 (21): 990.

https://doi.org/10.1182/blood.V124.21.990.990

Published: 2014

Journal Articles

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Blood (2014) 124 (13): 2034–2045.

https://doi.org/10.1182/blood-2014-04-571125

Published: 2014

Includes: Supplemental data

Journal Articles

Acute graft-versus-host disease: more than just alloreactivity

Richard Champlin

Blood (2014) 124 (2): 163–164.

https://doi.org/10.1182/blood-2014-05-575431

Published: 2014

Journal Articles

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Marcelo A. Fernández-Viña, John P. Klein, Michael Haagenson, Stephen R. Spellman, Claudio Anasetti, Harriet Noreen, Lee Ann Baxter-Lowe, Pedro Cano, Neal Flomenberg, Dennis L. Confer, Mary M. Horowitz, Machteld Oudshoorn, Effie W. Petersdorf, Michelle Setterholm, Richard Champlin, Stephanie J. Lee, Marcos de Lima

Blood (2013) 121 (22): 4603–4610.

https://doi.org/10.1182/blood-2013-02-481945

Published: 2013

Includes: Supplemental data

Journal Articles

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

Roy F. Chemaly, Santosh S. Hanmod, Dhanesh B. Rathod, Shashank S. Ghantoji, Ying Jiang, Arpan Doshi, Karen Vigil, Javier A. Adachi, Andrew M. Khoury, Jeffery Tarrand, Chitra Hosing, Richard Champlin

Blood (2012) 119 (12): 2738–2745.

https://doi.org/10.1182/blood-2011-08-371112

Published: 2012

Journal Articles

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Hagop Kantarjian, Susan O'Brien, Elias Jabbour, Guillermo Garcia-Manero, Alfonso Quintas-Cardama, Jenny Shan, Mary Beth Rios, Farhad Ravandi, Stefan Faderl, Tapan Kadia, Gautam Borthakur, Xuelin Huang, Richard Champlin, Moshe Talpaz, Jorge Cortes

Blood (2012) 119 (9): 1981–1987.

https://doi.org/10.1182/blood-2011-08-358135

Published: 2012

Journal Articles

Detection of Minimal Residual Leukemia Predicts the Outcome of Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy

Farhad Ravandi, MD, Deborah A. Thomas, MD, Susan O'Brien, MD, Rebecca Garris, BSc, Stefan Faderl, MD, Jianqin Shan, PhD, Gautam Borthakur, Jan A. Burger, MD, PhD, Alessandra Ferrajoli, MD, Partow Kebriaei, MD, Richard Champlin, MD, Zeev Estrov, Sa A. Wang, MD, Jeffrey L. Jorgensen, MD, PhD, Rajyalakshmi Luthra, PhD, Jorge E. Cortes, Hagop M. Kantarjian

Blood (2011) 118 (21): 1453.

https://doi.org/10.1182/blood.V118.21.1453.1453

Published: 2011

Journal Articles

Hematopoietic Cell Transplantation – Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic Transplantation

Ulas D. Bayraktar, MD, Elizabeth J Shpall, MD, Ping Liu, MS, Stefan O Ciurea, MD, Marcos De Lima, MD, Gabriela Rondon, MD, Kristen J Price, M.D., Richard Champlin, MD, Joseph L Nates, M.D.

Blood (2011) 118 (21): 147.

https://doi.org/10.1182/blood.V118.21.147.147

Published: 2011

Journal Articles

Long-Term Follow-up of Combined Hypercvad (hCVAD) Regimen with Dasatinib (Db) in the Front Line Therapy of Patients (pts) with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Hun Ju Lee, MD, Hagop M. Kantarjian, Deborah A. Thomas, MD, Stefan Faderl, MD, Charles Koller, MD, Alessandra Ferrajoli, MD, Elias Jabbour, Rebecca Garris, BSc, Partow Kebriaei, MD, Richard Champlin, MD, Gautam Borthakur, William G. Wierda, MD, PhD, Jan A. Burger, MD, PhD, Jorge E. Cortes, Susan O'Brien, MD, Farhad Ravandi, MD

Blood (2011) 118 (21): 1512.

https://doi.org/10.1182/blood.V118.21.1512.1512

Published: 2011

Journal Articles

Lenalidomide Treatment Enhances Immunological Synapse Formation of Cord Blood Natural Killer Cells with B Cells Derived From Chronic Lymphocytic Leukemia

Dongxia Xing, Ph. D., Alan G. Ramsay, PhD, Simon Robinson, PhD, Catherine M. Bollard, MD, Nina Shah, MD, Richard Champlin, MD, John G. Gribben, MD, DSc, Elizabeth J Shpall, MD

Blood (2011) 118 (21): 1794.

https://doi.org/10.1182/blood.V118.21.1794.1794

Published: 2011

Journal Articles

Allogeneic Hematopoeitic Stem Cell Transplantation (AHSCT) Versus Hypomethylating Agents (HMA) in Patients (pts) with Myelodysplastic Syndrome (MDS): A Case-Control Study

Maria F Tanaka, Elias Jabbour, Hagop M. Kantarjian, Sherry Pierce, RN, BS, Richard Champlin, MD, Marcos De Lima, MD, Guillermo Garcia-Manero

Blood (2011) 118 (21): 1707.

https://doi.org/10.1182/blood.V118.21.1707.1707

Published: 2011

NARROW

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

IL-10 + regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Cord Blood Derived Natural Killer Cells Engineered with a Chimeric Antigen Receptor Targeting CD19 and Expressing IL-15 Have Long Term Persistence and Exert Potent Anti-Leukemia Activity

Outcomes of Haploidenitical Stem Cell Transplants for De Novo Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Myeloid Leukemia Arising from MDS: The MD Anderson Experience

CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Acute graft-versus-host disease: more than just alloreactivity

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Detection of Minimal Residual Leukemia Predicts the Outcome of Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy

Hematopoietic Cell Transplantation – Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic Transplantation

Long-Term Follow-up of Combined Hypercvad (hCVAD) Regimen with Dasatinib (Db) in the Front Line Therapy of Patients (pts) with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Lenalidomide Treatment Enhances Immunological Synapse Formation of Cord Blood Natural Killer Cells with B Cells Derived From Chronic Lymphocytic Leukemia

Allogeneic Hematopoeitic Stem Cell Transplantation (AHSCT) Versus Hypomethylating Agents (HMA) in Patients (pts) with Myelodysplastic Syndrome (MDS): A Case-Control Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only